Effects of Cardio-Dance Fitness Versus Strength, Flexibility, and Balance Exercises on Brain Health and Alzheimers Risk in Older African Americans
Led by Rutgers, The State University of New Jersey · Updated on 2026-02-20
280
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying the effects of different types of exercise on brain health and Alzheimers disease risk in older African Americans. This research focuses on comparing Cardio-Dance Fitness CDF with Strength, Flexibility, and Balance SFB exercises, investigating their impact on cognitive markers and brain function related to Alzheimers. The study also explores how genetic variations in the ABCA7 gene may influence how individuals respond to these exercise programs.
Participants will be randomly assigned to one of two groups the CDF group, which involves aerobic cardio-dance classes held three times a week for about 60 minutes each session over six months, or the SFB active control group, which meets with the same frequency and duration but focuses on non-aerobic strength, flexibility, and balance exercises. Both interventions include social interaction and are designed to be engaging and structurally equivalent.
Throughout the study, participants will undergo health assessments, cognitive testing, structural and functional MRI scans, and blood draws at the start and end of the six-month intervention. These evaluations will measure changes in cognitive performance, brain neural flexibility, and Alzheimers biomarkers like amyloid and tau proteins. The researchers will monitor these outcomes to understand the effects of the exercise programs and the role of genetic factors in modifying these effects.
CONDITIONS
Brief Title
Exercise to Improve Brain Health in Older African Americans
Research Team
B
Bernadette A. Fausto, PhD
J
Jennifer Greene, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Cardio‑Dance Fitness
Strength, Flexibility & Balance
What it is
A six‑month, thrice‑weekly group aerobics cardio‑dance class (~60 min per session) taught in a social setting with heart‑rate monitoring.
A six‑month, thrice‑weekly group non‑aerobic strength, flexibility, and balance training class matching the schedule and social setting of the aerobic arm.
Role in trial
Investigational aerobic intervention designed to assess effects on cognition and neural flexibility.
Active comparator arm providing non‑aerobic exercise with equivalent structure to isolate the effect of aerobic activity.
Primary use
Being evaluated for improving cognitive generalization and medial temporal lobe neural flexibility in older African Americans.
Serves as a comparator to evaluate whether non‑aerobic activity influences the same cognitive outcomes.
How it is given or performed
Delivered as instructor‑led cardio‑dance sessions with heart‑rate monitoring three times per week for 24 weeks.
Delivered as instructor‑led non‑aerobic sessions three times per week for 24 weeks matching schedule of cardio‑dance arm.
Evidence status
Preliminary evidence in older African American adults shows cardio‑dance may improve attention and mood compared with no exercise control.
Evidence specific to non‑aerobic strength/flexibility/balance training alone in this population is limited.
Important limitations
Existing evidence comes from a small non‑randomized cohort without active comparator; effects on cognition and neural markers remain untested in this randomized trial.
Lacks established evidence for cognitive impact as a standalone active comparator in African American older adults.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 60Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Self-identify as African American or Black
Age 60 years or older
Able to speak, read, and understand English
Available over the study period
Able to walk independently without wheelchair, walker, or cane
Low physical activity levels (less than 60 minutes per week) based on International Physical Activity Questionnaire
Score between 28 and 35 on the Telephone Interview for Cognitive Status Modified
Score between 20 and 26 on the Montreal Cognitive Assessment during screening
Have clearance to participate from primary care physician with oversight by study physician
You will not qualify if you...
Color blindness
Diagnosed neurological disorders including headaches and peripheral neuropathy
Diagnosed or self-reported non-neurological conditions likely affecting brain outcomes such as major depressive disorder (or Geriatric Depression Scale-Short Form score ≥ 5), schizophrenia, delusional disorder, schizoaffective disorder, psychosis, substance-related and addictive disorders (or treatment in past five years)
Chemotherapy or radiation treatment for cancers
Planning to undergo general anesthesia during the study period
Exercise contraindications including orthopedic complications, recent heart attack, coronary artery bypass grafting, angioplasty, current congestive heart failure treatment, angina, uncontrolled arrhythmia, deep vein thrombosis, other cardiovascular events, or uncontrolled hypertension with blood pressure > 180/110 mmHg
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 24 weeks (approximately 6 months)
Participants engage in either a Cardio-Dance Fitness exercise or a Strength, Flexibility & Balance exercise program to improve brain health.
Three exercise sessions per week, approximately 60 minutes each
Follow-up
Duration - At enrollment and post-intervention
Participants complete health assessments, cognitive tests, MRI scans, and blood draws at enrollment and after the intervention to evaluate changes.
2 visits (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
AGIL Barcelona Program to Improve Physical Abilities and Delay Disability in Frail Older Adults
A Study of Integrated Care and Community Support in Barcelona
100-Year Human Aging Study Long-Term Follow-Up of Multi-System Health Measures to Predict Mortality and Aging Outcomes
Comparing Cardiac 18F-MFBG PET and 123I-MIBG SPECT to Differentiate Parkinsons Disease, Multiple System Atrophy, Dementia with Lewy Bodies, and Alzheimers Disease
Phase 3 Study of PET Imaging With 18FPI-2620 to Detect Tau Protein in Alzheimers Disease Compared to Brain Autopsy
Effects of Combined Aerobic, Resistance, and Cognitive Training on Brain Function in Older Adults With Cardiovascular Risk Factors
Feasibility Study of the Green Activity Program to Support People 45 and Older with Memory Challenges and Their Study Partners
Safety and Effects of LY3954068 Delivered into Spinal Fluid in Adults 50 to 85 Years Old With Early Alzheimers Disease
Study on How Gut Microbiome Affects Brain Health in Alzheimers Disease from Normal Cognition to Dementia
Multidomain Lifestyle Intervention to Prevent Cognitive Decline in Older Adults at Risk in Zhejiang, China
Evaluating Multifocal Non-Invasive Brain Stimulation and Cognitive Training to Improve Symptoms in Mild Cognitive Impairment and Early Dementia
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Examining the efficacy of a cardio-dance intervention on brain health and the moderating role of ABCA7 in older African Americans: a protocol for a randomized controlled trial.
Mark A Gluck, Joshua L Gills, Bernadette A Fausto...